News Releases
Mar 20 2024
Avid Bioservices Announces Receipt of Deficiency Notice from Nasdaq Regarding Late Form 10-Q
Mar 6 2024
Avid Bioservices Announces Pricing of Private Placement of Convertible Notes
Mar 6 2024
Avid Bioservices Announces Proposed Private Placement of Convertible Notes
Mar 6 2024
Avid Bioservices Announces Certain Preliminary Financial Results for Third Quarter Ended January 31, 2024
Dec 7 2023
Avid Bioservices Reports Financial Results for Second Quarter Ended October 31, 2023
Nov 30 2023
Avid Bioservices to Report Financial Results for Second Quarter of Fiscal Year 2024 After Market Close on December 7, 2023
Nov 8 2023
Avid Bioservices Partners With California Institute for Regenerative Medicine (CIRM) to Provide CDMO Services for Cell and Gene Therapy (CGT) Programs
Oct 17 2023
Avid Bioservices Completes Construction of New, World-Class Cell and Gene Therapy Development and Manufacturing Facility
Sep 26 2023
Avid Bioservices to Participate in RBC Capital Markets Virtual CDMO Conference
Sep 7 2023
Avid Bioservices Reports Financial Results for First Quarter Ended July 31, 2023